Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
8
×
drugs
8
×
life sciences
national blog main
national top stories
san diego blog main
san diego top stories
8
×
san francisco blog main
boston blog main
boston top stories
detroit blog main
detroit top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
indiana blog main
indiana top stories
national
biotech
fda
startups
deals
roche
abbvie
gene therapy
investing
pfizer
synthetic biology
agios pharmaceuticals
What
drug
bio
fda
roundup
san
american
annual
approved
ash
big
blood
companies
conference
diego
disease
drugs
gathering
largest
medical
new
society
week
admits
advance
ago
ahead
alzheimer’s
asco
assessed
attention
biologic
biology
biotech
biotechs
borne
branded
cancer
cancers
choices
classes
Language
unset
Current search:
drugs
×
cancer
×
" san diego top stories "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
